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Précis  6 
To help eliminate perinatal HIV transmission, the US Department of Health and Human Services 7 
recommends against breastfeeding for women living with HIV, regardless of viral load or 8 
combined antiretroviral therapy (cART) status. However, cART radically improves HIV 9 
prognosis and virtually eliminates perinatal transmission, and breastfeeding’s health benefits are 10 
well-established. In this setting, pregnancy is increasing among American women with HIV, and 11 
a harm reduction approach to those who breastfeed despite extensive counseling is suggested. 12 
We assess the evidence and ethical justification for current policy, with attention to pertinent 13 
racial and health disparities. We first review perinatal transmission and breastfeeding data 14 
relevant to US infants. We compare hypothetical risk of HIV transmission from breastmilk to 15 
increased mortality from sudden infant death syndrome, necrotizing enterocolitis and sepsis from 16 
avoiding breastfeeding, finding that benefits may outweigh risks if mothers maintain 17 
undetectable viral load on cART. We then review maternal health considerations. We conclude 18 
that avoidance of breastfeeding by women living with HIV may not maximize health outcomes 19 
and discuss our recommendation for revising national guidelines in light of autonomy, harm 20 
reduction and health inequities. 21 
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Introduction 
To help eliminate perinatal HIV transmission, the United States Department of Health and 
Human Services (DHHS) strongly recommends avoidance of breastfeeding for women living 
with HIV (WLHIV), regardless of maternal viral load or combined antiretroviral therapy (cART) 
status.[1,2]  However, cART radically improves HIV prognosis and virtually eliminates perinatal 
transmission, and breastfeeding’s benefits are well-established.[3,4] As more US WLHIV are 
pursuing pregnancy, some breastfeed despite recommendations, for which a harm reduction 
approach is proposed.[1,5-9] Conversely, breastfeeding is recommended for WLHIV in low-
income-countries given high-quality randomized controlled trials demonstrating 1-2% total 
perinatal transmission and decreased child mortality with cART starting in the third trimester and 
continued during breastfeeding.[10] However, these data come from settings where child 
mortality is high, largely from gastrointestinal and respiratory infections, and replacement 
feeding is often not “affordable, feasible, acceptable, sustainable or safe,” limiting 
generalizability to US populations.  
 
To assess US policy, we conducted a critical review of primary, secondary and gray literature 
relevant to perinatal transmission, risks and potential health benefits of breastfeeding for infants 
and women in high-income settings. US health surveillance data, government and professional 
society guidelines were reviewed.[11] Pubmed, EMBASE, Cochrane, Web of Science and 
Google searches were performed in 10/2016 and periodically updated through 9/2018. Scoping 
review of literature cited in official documents and review articles was performed. MG 
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conducted the review; findings were vetted by HT, CT, and JC in their respective areas of 
expertise. Supporting data and nonessential references are included in online supplement due to 
space constraints.  
 
First, we delineate the risk of HIV transmission from breastfeeding for HIV-exposed US infants.  
Next, we delineate the risks to this same population of children if they are not breastfed, 
including excess mortality from sudden infant death syndrome (SIDS), necrotizing enterocolitis 
(NEC) and sepsis. We then discuss maternal health considerations. We conclude that strict 
avoidance of breastfeeding by WLHIV may not maximize health outcomes, particularly given 
existing infant and maternal health disparities (see Figure 1). Supported by ethical considerations 
of autonomy, harm reduction and social justice, we suggest eliminating the categorical 
recommendation against breastfeeding for cART-adherent WLHIV. 
 
Clinical Considerations1 
 
Risk of Perinatal HIV from Breastfeeding 
Perinatal transmission in high-income-countries continues to decrease with more effective, 
tolerable cART and treatment upon HIV diagnosis, including in pregnancy.[12] Approximately 
8700 (95% CI: 8400-8800) US WLHIV deliver annually.[5] In 2014 an estimated 63 infants 
                                                          
1 See data tables 1-3 in online supplement. Insert Figure 1 at beginning of Clinical 
Considerations section 
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(0.8%) contracted perinatal HIV.[13] However, viral load (VL) is the greatest predictor of 
perinatal transmission, and infants whose mothers have detectable VL (>50 copies/ml) are 
disproportionately affected.[14] Factors that increase the risk of perinatal transmission include 
high VL, as in acute HIV during pregnancy or breastfeeding, non-adherence with cART, 
inadequate prenatal care, injection drug use, substance use, CD4  T cell count ˂200, age ≤24, 
genital infections, and not receiving DHHS recommended antepartum cART, intrapartum care or 
postpartum infant prophylaxis.[14-17]  
 
Conversely, cART-adherent women with undetectable VL near delivery have very low perinatal 
transmission rates, e.g. 0.05% from 2000-2011 per United Kingdom/Ireland national surveillance 
data.[12] Those who transmit HIV despite attaining undetectable VL before delivery have 
significant obstetrical risks, such as premature rupture of membranes of unknown duration in the 
setting of placenta previa, placental abruption, or preterm delivery shortly after achieving 
virologic control.[14] Initiation of cART early in pregnancy further reduces transmission, 
irrespective of VL. A French national cohort had 0.2% transmission with preconception cART 
vs. 0.4%, 0.9%, and 2.2% with first, second, or third trimester initiation.[15] The DHHS states 
that VL should be undetectable on cART before attempting conception.[1] In France (n=2615) 
and United Kingdom/Ireland (n=1894), transmission was 0.0% with preconception cART and 
undetectable VL near delivery.[12,15] 
 
However, evidence above does not account for risk of breastmilk transmission, since high-
income governments recommend WLHIV avoid breastfeeding. These policies have discouraged 
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the study of breastfeeding outcomes in high-income settings, and current US perinatal HIV 
exposure data are insufficient for guiding practice.[17] For example, a chart review of HIV-
exposed infants found that perinatal HIV was more common among the 1% (80/8054) who 
breastfed (aOR 4.6, 95% CI 2.2-9.8), however key details like maternal VL were omitted.[16] 
Meanwhile, in our 2016 survey, 33% of providers reported having patients who breastfeed 
despite recommendations, and latest US guidelines have introduced a harm reduction approach, 
suggesting possible ascertainment bias in the review above in which perinatal HIV cases may 
have been more likely to have their breastfeeding status exposed.[18] Surreptitious breastfeeding 
and coincident nonadherence with other perinatal HIV recommendations may further confound 
the picture, though a harm reduction approach may attenuate these concerns moving forwards.  
 
In contrast, a 2011 systematic review found 8 studies from low-income settings in which  
breastfeeding for 6 months was associated with 0–1% perinatal transmission (n=3202).[9] In 
Mma Bana, the largest cohort in the review, 709 women initiated cART between 26-34 weeks of 
pregnancy, and at 6 months postpartum there were two breastmilk transmissions (0.3%): one 
mother was non-adherent with medications, and the other had VL >170,000, delivered 
prematurely, and breastfed before achieving viral suppression.[17] One meta-analysis was 
identified which included 6 studies (n=2109) with pooled transmission of 1.08% (95% CI 0.32-
1.85) over 6 months of breastfeeding, though this was deemed ‘very low’ quality evidence, and 
applicability to US population is limited by absent VL or adherence data, late initiation of cART, 
and lack of standard postnatal infant prophylaxis.[20] The more recent PROMISE study 
(n=2431) also found 0.3% transmission through 6 months of breastfeeding.[21] Breastmilk 
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transmission in high-income settings may be similar, and cART-adherence with undetectable VL 
may virtually eliminate transmission risk, much as it has from pregnancy and delivery.  
 
Health Benefits of Breastfeeding for Infants 
Breastfeeding decreases major causes of US infant mortality, including SIDS and complications 
of prematurity.[3,4,22] In a meta-analysis of 23 studies, SIDS was half as likely among breastfed 
vs. formula-fed infants.[4] NEC and sepsis have highest incidence among non-breastfed 
premature and low birthweight infants, and mortality is inversely related to weight and 
gestational age.[4,22-24] Prematurity and low birthweight affects 11.4% and 8.2% of US infants, 
respectively, and breastfeeding decreased NEC 58% in four randomized-controlled trials and 
urosepsis 69% in a large preterm cohort.[4,23] A UK study modeling preterm infant feeding 
estimated 190 excess deaths from NEC or sepsis annually if no premature infants breastfeed 
(n=51,703).[24] 
 
Notably, black infants suffer 2.2-fold mortality (3.5-fold preterm-related death) and black 
women have twentyfold higher incidence of HIV when compared to white counterparts.[22,25] 
Thus, accounting for existing health disparities is critical for appreciating potential benefits of 
breastfeeding in this population. For example, SIDS causes 38.7 deaths/100,000 US livebirths, 
but 74.0/100,000 for black infants.[26] HIV-exposed US infants are also more likely to have low 
birthweight (22.9%, n=980) or be preterm (18.6% overall, and 21% among women receiving 
cART in the first trimester; n=1869).[27] If US WLHIV breastfed, there may be significantly 
fewer SIDS and prematurity-associated deaths among their infants.  
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Breastfeeding also prevents potentially fatal gastroenteritis (OR 0.36, 95% CI 0.18–0.74) and 
hospitalization for respiratory infections (RR 0.28, 95% CI 0.14–0.54) for US infants.[4,26] 
Acute otitis media, which affects ˃80% under 3 years, is decreased 50% with breastfeeding.[4] 
Victora et al presented confounder-adjusted meta-analyses showing: 35% reduction in type 2 
diabetes; 13% lower rate of overweight/obesity; 9% reduction in asthma; 19% reduction of 
childhood leukemia; and, an increase in child intelligence quotient (IQ) of 3.4 points.[3] 
Exclusive breastfeeding during the first 6 months of life with continued breastfeeding for at least 
the first year is the most effective strategy for conferring these benefits, and is the normative 
standard for infant feeding in high income settings.  
 
Weighing Risks and Benefits for Infants 
To determine the best feeding method for HIV-exposed US infants, we must reconcile the 
hypothetical increased duration of perinatal transmission risk with current excess health risks 
from lack of breastfeeding, as outlined above.[28] First, while breastmilk transmission in low-
income-countries is <1% with cART, many of the data come from clinical trials, which may 
affect cART-adherence by providing medications and other support. For example, in Mma Bana 
>90% achieved and maintained viral suppression during pregnancy and 6 months of 
breastfeeding.[19] Although cART uptake among US WLHIV is increasing over time, adherence 
remains suboptimal: population-based data from New York State 2008-2010 (n=980) 
demonstrated that only 75% were virally suppressed at delivery, and among those, just 44% 
remained suppressed one year postpartum.[28] Retrospective studies from Mississippi and 
Philadelphia found that <40% were optimally engaged in HIV care throughout the year after 
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delivery.[29] Postpartum non-adherence to cART and loss to care among US WLHIV yield 
significant concerns about the safety of breastfeeding for their infants.  
 
Simultaneously, data demonstrate how HIV diagnosis >2 years before pregnancy, preconception 
HIV care, early and adequate prenatal care, older maternal age, viral suppression at delivery and 
low infant birthweight, among other factors, can predict postpartum retention in care and 
sustained viral suppression.[29-32] Documented breastmilk transmissions appear to occur with 
cART nonadherence, detectable VL, or loss to follow up, and known risk factors could inform 
individualized infant feeding recommendations. Momplaisir et al highlight the interpersonal, 
community and health systems-level issues impacting postpartum retention, suggesting a five-
pronged approach to improve outcomes.[30] Importantly, a substantial proportion of US WLHIV 
do maintain ongoing viral suppression, and breastfeeding itself may increase postpartum cART-
adherence by prolonging unified maternal and child interests. Development of clinical algorithms 
to identify candidates for breastfeeding, and support for postpartum retention in HIV care would 
be crucial for introducing personalized feeding recommendations for HIV-exposed US infants. 
 
Notably, in the US, perinatal HIV is a serious, but chronic disease with very low mortality 
(0.05/100 child-years) and morbidity dominated by treatment side-effects.[33,34] Thus, 
breastmilk transmission of HIV may not substantially impact infant mortality, and any increased 
HIV-morbidity might be compensated for by breastfeeding’s health benefits. One concern 
regarding potential HIV-related morbidity is risk of genotypic resistance for perinatally infected 
infants whose mothers breastfeed without viral suppression. However, this is less likely to 
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impact US infants, as it has occurred among low-income-countries among infants, including 
those infected antepartum/intrapartum, who received prolonged antiretroviral prophylaxis for 
breastfeeding in lieu of maternal cART or whose mothers first initiated cART postpartum.[35] 
 
Finally, regarding theoretical increased drug toxicity for infants via breastmilk or prolonged 
prophylaxis, studies have shown that severe adverse events (SAEs) are equally rare for 1 vs. 28 
weeks of breastmilk exposure, and found no differences between breastfeeding infants receiving 
6 weeks vs. 6 months of prophylaxis.[10,36] While infant antiretroviral prophylaxis and 
breastmilk exposure appear safe and well tolerated, recommendations for optimal maternal 
treatment and infant prophylaxis during breastfeeding and weaning in US populations continue 
to evolve.[1,37]  
 
Overall, the significant benefits of breastfeeding may outweigh risks for infants of cART-
adherent US WLHIV. Likewise, while 6 months of breastfeeding may confer the majority of 
benefits with acceptably low risk, the duration of breastfeeding that would optimize 
risks/benefits for infants is beyond the scope of this discussion, but important to address. A 
statistical model would be helpful for extrapolating how alternative feeding recommendations 
would impact morbidity and mortality for HIV-exposed US infants. 
 
Health Benefits of Breastfeeding for Women 
Breastfeeding also affects leading causes of US women’s mortality, including heart disease (#1), 
cancer (#2), diabetes (#7), and hypertension (#13).[26] In the Nurses’ Health Study (n= 89,326), 
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2 years of cumulative breastfeeding reduced myocardial infarction by 23%, and any 
breastfeeding decreased hypertension, diabetes and hyperlipidemia, with direct dose-
response.[38] Breastfeeding also decreases stroke by 23%.[39] Meta-analysis showed that 
breastfeeding decreased type 2 diabetes by 32% (RR 0·68, 95% CI 0·57–0·82).[3] Breastfeeding 
consumes ~480 kcal/day, increasing postpartum weight loss, and body mass index was 1% lower 
per 6 months of breastfeeding among 740,000 British women.[3,40] 
 
Breast cancer is US women’s most common cancer and second leading cause of cancer 
death.[26] Victora et al report adjusted metaanalyses demonstrating 7% reduction of invasive 
breast cancer with breastfeeding in high-income-countries, and worldwide premenopausal breast 
cancer decreased 4.3% per year of breastfeeding.[3] Ovarian cancer is the fifth leading cause of 
US women’s cancer death, and breastfeeding reduces risk by 30%.[3,26] In a 2017 meta-
analysis, risk of endometrial cancer, the most common gynecologic malignancy among US 
women, was decreased 11% with breastfeeding.[41]  
 
Per the American College of Obstetricians and Gynecologists, "underserved women are 
disproportionately likely to experience adverse health outcomes that may improve with 
breastfeeding.”[40] WLHIV are predominantly socioeconomically disadvantaged women of 
color, and avoiding breastfeeding compounds their already increased obesity, hypertension, 
diabetes, heart disease, stroke and cancer risks.[25,33] For example, black women are especially 
susceptible to hormone-and-triple-negative breast cancers, whereas breastfeeding could decrease 
that risk by 19%.[42] While causality remains unclear, postpartum depression has a strong 
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inverse relationship to breastfeeding, and current guidelines may worsen WLHIV’s undue 
psychiatric morbidity.[3,43] 
  
Lastly, exclusive breastfeeding induces lactational amenorrhea, preventing 98% of pregnancies 
for six months.[44] This significantly reduces risks of subsequent short interval pregnancies: 
maternal and infant death, uterine rupture, placental abruption, placenta previa, preterm rupture 
of membranes, fetal growth restriction and premature delivery.[45] WLHIV, like many minority 
and low-income women, disproportionately experience unintended pregnancies and their 
sequelae.[40] Ultimately, breastfeeding protects US women’s health, and recommending against 
breastfeeding especially harms minority and low-income women. 
 
Ethical Considerations 
Autonomy 
Our review illustrates the clinical equipoise regarding optimal feeding practices for US 
WLHIV.[37,46] Critically, the prevailing argument that curtailing women’s autonomy is 
justified given the value of protecting infants’ best interests is undermined by the potential 
benefits of breastfeeding for infants whose mothers maintain undetectable VL. The addition of 
“patient-centered, evidence-based counseling” for women who question the recommendation 
against breastfeeding and harm reduction strategies for “when women with HIV choose to 
breastfeed despite intensive counseling” make major strides towards respecting women’s 
autonomy.[1] However, discussing breastfeeding as a matter of maternal “choice” may trivialize 
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the health benefits that infants and women stand to gain. Yet, current guidelines state that 
“breastfeeding is not recommended [sic]” and prompt providers to address “potential barriers to 
formula feeding,” falling short of the genuine shared-decision making clinical equipoise 
enjoins.[1]  
 
While DHHS recommendations do not have the force of law, legal authority has loomed large 
for WLHIV who attempt to breastfeed.[47] The American Academy of Pediatrics has suggested 
the “rare circumstance” in which women with undetectable VL on cART may breastfeed 
“despite intensive counseling” without constituting “grounds for automatic referral to Child 
Protective Services.”[2] Women cannot make free, informed choices if they fear breastfeeding 
may jeopardize parental rights, particularly when “intensive counseling” continues immediately-
postpartum period, when lactation support is critical for successful breastfeeding. Telling women 
not to breastfeed may also subject them to social pressure, grief, shame, and guilt, further 
curtailing maternal autonomy.[48] 
 
The availability of safe formula in the US is cited as justification for the recommendation against 
breastfeeding for WLHIV.[1] Instead, donor human milk and formula could be a part of a shared 
decision-making framework that could facilitate informed collaboration between WLHIV and 
their physicians.[49] Frequent healthcare visits during pregnancy and infancy allows for ongoing 
risk-benefit assessments and close monitoring. Anticipatory guidance and heightened 
surveillance paired with skilled breastfeeding support help minimize transmission risk, for 
example, by promoting early detection of mastitis and prompting unilateral pumping and 
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discarding of breastmilk during acute infection.[1] Recent updates to DHHS guidelines offer 
support for WLHIV who breastfeed “despite intensive counseling” and provide valuable 
practical guidance for providers regarding postpartum management. However, clinical equipoise 
regarding infants’ interests suggests that the recommendation against breastfeeding may be 
replaced with individualized, evidence-based recommendations and strategies to promote cART-
adherence.  
 
Harm Reduction 
Acknowledging that a wide range of factors, from familial pressures and stigma to awareness of 
health benefits and desire for bonding, may lead WLHIV to breastfeed contrary to US 
recommendations, Levison and others have promoted a harm reduction approach.[7,8] They 
argue that a hardline stance against breastfeeding may increase perinatal transmission by 
prompting some to conceal their choice from providers and others to avoid treatment 
altogether.[7] They emphasize replacement feeding as optimal, but suggest exclusive 
breastfeeding with cART for “those who decide to breastfeed despite being fully informed of the 
risks.” Harm reduction compassionately recognizes the difficult, often complex choices 
individual WLHIV face. Critically, its adoption may assuage providers’ fear of legal or 
professional repercussions from promoting informed feeding choices.  
However, harm reduction and current DHHS Recommendations treat breastfeeding with HIV as 
a harm, and thus may not be the appropriate framework for approaching this issue. First, with 
cART-induced viral suppression, breastfeeding’s health benefits may outweigh its risks, whereas 
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avoiding breastfeeding may cause net harm. Likewise, routine cesarean delivery for WLHIV was 
discontinued given evidence that iatrogenic harms from surgery outweighed marginal reductions 
in perinatal transmission when risk was already very low due to maternal virologic control.[1,9] 
Furthermore, retaining the expectation that WLHIV avoid breastfeeding and asserting that 
breastfeeding is “reasonable but inferior,” introduces judgement that may unintentionally 
jeopardize forthright patient-provider interactions, compromising both shared decision-making 
and the disclosure required for breastfeeding women to participate in observational studies.  
Finally, 84% of HIV healthcare providers have stated that they would require government and/or 
professional society guidelines before supporting breastfeeding among WLHIV with 
undetectable VL, and the DHHS continues to strongly recommend against breastfeeding. It is 
unclear whether acceptance of harm reduction truly satisfies those criteria for individual 
providers or if it will lead to corresponding updates in hospital and health system policies.[18] In 
this regard, harm reduction may be insufficient to substantially change practice, promote 
informed decisions or close evidence gaps.  
 
Health and Socioeconomic Inequities 
Current recommendations against breastfeeding likely further disadvantage already 
disadvantaged women and infants, largely due to existing socioeconomic and racial disparities. 
Unfortunately, minority women suffer disproportionately from diseases breastfeeding may 
prevent, such as obesity, hypertension, heart disease, stroke, depression and female cancers.[39-
42] Additionally, current policy imposes financial hardship via formula’s costs, including loss of 
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Women Infant and Children (WIC)’s breastfeeding incentives, and lost wages due to infant or 
maternal illness.[50,51] Ironically, WLHIV who adhere to healthcare recommendations generally 
are least likely to transmit HIV and most likely to experience current recommendations as unjust. 
The extent to which postpartum adherence can be addressed by increasing awareness, care 
coordination, peer-and-technology-based interventions, and long-acting cART formulations puts 
the onus on the US healthcare system to close gaps that undermine WLHIV’s access to 
breastfeeding’s benefits.  
 
Further, HIV-exposed US infants disproportionately experience health risks that could be 
mitigated by breastfeeding. In 2013, mortality for black infants was more than double that of 
white infants, chiefly attributed to greater burdens of prematurity and SIDS.[22] Since 
preconception cART is associated with prematurity and low birthweight, the HIV-exposed 
infants least likely to contract HIV are most likely to be harmed by not breastfeeding.[27]  
Socioeconomically disenfranchised infants would especially benefit from decreased diabetes, 
obesity, and asthma, plus a higher IQ with corresponding adult educational attainment and 
income. While donor breastmilk may partially alleviate consequences of current policy, most 
HIV-exposed infants do not have access to banked milk, and breastfeeding itself is more 
beneficial, feasible, and cost-effective.[28,52] Discouraging WLHIV from breastfeeding may 
inadvertently contribute to poor health outcomes among vulnerable infants and women, 
systematically reinforcing racial inequity by deepening disparities in health and wealth.[53,54] 
 
Conclusion and recommendations 
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Given potential benefits of breastfeeding and very low perinatal transmission risk with 
undetectable VL, breast may be best for infants of cART-adherent WLHIV. As with decisions 
about having children, WLHIV have a right to make an informed choice about breastfeeding, 
especially given clinical equipoise regarding infant outcomes, maternal health considerations and 
personal significance. Additionally, women and select HIV-exposed infants may be harmed by 
avoiding breastfeeding, and further policy change may be required to fully support shared-
decision making, necessitating an approach beyond harm reduction. Finally, avoiding 
breastfeeding may inadvertently increase health inequities by further disadvantaging WLHIV 
and their infants. 
 
We suggest DHHS recommendations include breastfeeding as an option for cART-adherent 
WLHIV who maintain undetectable VL, ideally within a prospective cohort emphasizing 
informed consent and close observation. Clinical tools should be developed to help providers 
identify dyads who may safely breastfeed and to facilitate shared-decision making, and care 
should be taken to ensure that patient counseling is unbiased and evidence-based. Case 
management should ensure ongoing cART access, and donor milk or, if unavailable, formula 
should be subsidized when breastfeeding is not recommended or desired.  
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SIDS
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Asthma
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Short Birth 
Interval
2nd Sibling
SGA
LBW
Perinatal Death
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Placental 
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Placenta 
previa
Health problems for which 
WLHIV and their infants have 
increased baseline risk due to 
health disparities
 
 
NEC= necrotizing enterocolitis, GE=gastroenteritis, PNA=pneumonia, AOM=acute otitis media, UTI=urinary tract infection, DM=diabetes mellitus, 
LBW=low birthweight, PTB=preterm birth, HTN=hypertension, CAD=coronary artery disease, MI=myocardial infarction, CS=cesarean section 
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Table 1: Risk of Vertical Transmission of HIV with cART 
Ref Location 
* indicates 
breastfeeding 
population 
Study Group Study design Years  
(data 
collection, if 
available, or  
publication) 
Data 
 
BF= breastfeeding; VL= viral load; (c)ART= (combined) antiretroviral therapy; VT= vertical 
transmission (of HIV) 
 
 
 
 
1 United Kingdom  
and  
Ireland 
 
 
 
National Study 
of HIV in 
Pregnancy and 
Childhood 
(NSHPC) 
National 
surveillance 
data 
2000-2011 
▫ 12,486 HIV-exposed infants delivered from 2000-2011 in the UK/Ireland. 
▫ VT declined from 2.1% in 2000-2001 (17/816, 95% CI: 1.2–3.3%) to 0.46% in 2010-
2011 (9/1975, 95% CI: 0.21–0.86). 
▫ VT was 0.09% (6/6345) with undetectable VL (<50 copies/ml) near delivery, and 0.05% (2/3859) 
with undetectable VL on cART.   
▫ With preconception cART: 93% had undetectable VL at delivery (1894/2045), 5% were virally 
suppressed (50–399 copies/mL; 101/2045), and 2% had ≥400 copies/mL (50/2045).  
▫ With preconception cART: overall VT was 0.19% (4/2105), and VL was detectable (n = 3) or 
missing (n = 1) for transmitting mothers.  
▫ No transmissions occurred among those with preconception cART and undetectable VL at delivery 
(n=1894).  
 
 
2 
France 
French 
Perinatal 
Cohort 
Prospective 
cohort 
2000-2011 
▫ 8075 HIV-exposed infants delivered from 2000-2011.  
▫ VT was 0.2% (6/3505) with preconception cART, vs. 0.4% (3/709), 0.9% (24/2810), and 2.2% 
(23/1051) for those starting during the first, second, or third trimester (P < .001). 
 
 
3 
United States 
Ponce Family 
and Youth 
Clinic of the 
Grady Health 
Systems 
Retrospective 
chart review 
2005-2012 
▫ In review of all perinatal HIV cases treated in a regional referral center Atlanta, GA during this 
period, 24/27 (89%) were delivered by mothers with detectable VL. 
▫ Of those perinatally infected infants who delivered in the setting of undetectable VL, each had 
additional risk factors: prolonged rupture of membranes of unknown duration, placental abruption, 
and preterm delivery after third trimester VL >100,000. 
▫ Clear risk factors for VT: insufficient cART and/or prenatal care, illicit drug use  
 
 
 
4 United States 
 
 
 
IMPAACT  
Prospective 
cohort 
2002-2011 
▫ In this multicenter study, 671 ART-naïve women started cART during pregnancy and 13.1% had a 
detectable VL at delivery. 
▫ 91.4% (117/128), 87.7% (399/455) and 76.1% (67/88) starting in first, second and third trimesters, 
respectively, achieved undetectable VL by delivery (P = 0.003). 
▫ The only case of VT (0.2%) in this cohort had third trimester initiation, nonadherence to cART, 
and VL >1000 near delivery. 
 
 
5 
Malawi, 
Mozambique, 
Tanzania, 
Rawanda, 
Botswana, 
Uganda, and 
Kenya* 
DREAM, 
Mitra, Mitra 
Plus, 
AMATA, 
Mma Bana, 
Kisumu 
Systematic 
review  
2001-2009 
▫ In 8 high quality clinical trials, up to 6 months of exclusive BF while on cART was associated 
with 0–1% postnatal VT.  
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6 
South Africa, 
Malawi, 
Tanzania, 
Uganda, Zambia, 
Zimbabwe and 
India* 
 
 
 
PROMISE  
Randomized 
controlled 
trial  
2006-2011 
▫ Postnatal VT (n=2431) after 6, 9 and 12 months of BF with maternal cART was 0.3% (95% CI 
0.1-0.6), 0.5% (95% CI 0.2-0.8) and 0.6% (95% CI 0.4-1.1), respectively.  
 
 
7 
Botswana* Mma Bana 
Randomized 
controlled 
trial 
2006-2008 
730 women initiated cART from 26-34 weeks: 
▫ At enrollment: 13.6% had VL ≤1000, 19.6% had VL ≥100,000 and 23.3% had AIDS.  
▫ At 6 months postpartum, >90% had achieved and maintained viral suppression (<400 copies/mL) 
during pregnancy and BF. 
▫ Total VT was 1.1% (8/709), with 0.3% postnatal transmissions (2/709).  
▫ Of the two postnatal transmitting mothers, one postnatal had undetectable VL at delivery but 
subsequent “adherence issues” (by pill count or self-report); the other had VL >170,000 at 
enrollment and delivered at 32 weeks with a detectable VL. 
 
 
8 
Malawi* 
 
 
BAN Randomized 
controlled 
trial 
2004-2010 
849 infants BF for 28 weeks while mothers took cART: 
▫ Grade 3 or 4 adverse events included: 0.4% transaminitis (3), 19.6% anemia (166), 0.5% 
leukopenia (4), 1.1% thrombocytopenia (9), and 0.1% hypersensitivity rash (1). 
▫ These infants did not have an increased rate of events compared to 668 controls with just 1 week 
of postpartum maternal prophylaxis (RR 1.1; 95% CI 0.86-8.45). 
9 Tanzania* 
Kilombero and 
Ulanga 
Antiretroviral 
Cohort 
(KIULARCO) 
Prospective 
cohort  
2013-2016 
215 women started ART before delivery, and continued it while exclusively BF for ≥ 5 months: 
▫ During BF, 91% of mothers had VL <1000 copies/mL, with 75% <100 copies/mL. 
▫ Two infants (1%) were infected from BF: one mother had high VL(144,111 copies/mL) one month 
postpartum, and the other mother stopped ART during BF. 
▫There was no VT through BF among mothers with suppressed VL in this cohort 
10 
Mozambique,  
Malawi, Kenya, 
South Africa, 
Tanzania, 
Uganda, 
Zimbabwe, and 
India* 
HPTN046 
trial, Kisumu, 
BAN, 
DREAM, 
Mitra Plus, 
Vicente Ferrer 
HIV Cohort 
Study 
(VFHCS) 
Systematic 
review and 
meta-analysis 
2003-2010 
Meta-analysis of 6 studies, including 3 cohorts embedded in RCTs and 3 observational studies, 
published 2009-2012, comprising 2109 BF infants with mothers on cART: 
▫ In pooled analysis, postpartum VT after 6 months of BF was 1.08% (95% CI 0.32-1.85), with 
range 0.24% (1/413; 95% CI 0.0%-1.40%) to 3.10% (4/127; 95% CI 1.20%-7.80%). 
▫Limited or absent maternal VL or adherence data, routine initiation of cART late in pregnancy for 
majority of participants, many BF without viral suppression, rare preconception cART only in the 
setting of advanced HIV/AIDS, and infants did not receive current standard-of-care prophylaxis. 
▫ Very low quality evidence (GRADE profile) with “very serious” risk of bias, “very serious” 
inconsistency (I2=66.4%), “serious” indirectness, “not serious” imprecision. 
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Table 2: Impact of Breastfeeding on Infant Health in High Income Countries 
Ref Location Study design  
Years 
(data 
collection, if 
available, 
or  
publication) 
Data 
 
BF= breastfeeding; (c)ART= (combined) antiretroviral therapy; SIDS= sudden infant death syndrome; NEC= necrotizing 
enterocolitis 
11 International 
National 
surveillance 
data 
2014 
▫ Under-5 child mortality is 6.5/1000 in the US, vs. 83.1/1000 livebirths in Sub-Saharan Africa  
▫ Gastrointestinal and respiratory infections are leading causes of child mortality in low-income-countries, but not in high-
income-countries. 
▫ In the US 83% of under-5 child deaths occur in the first year of life, a similar proportion to low-income-countries. 
12 
United 
States 
National 
surveillance 
data 
2013 
▫ Infant mortality (5.96/1000 livebirths) is predominantly from complications of prematurity (36.1%) (eg. NEC, sepsis), 
and SIDS (6.7%). 
▫ Preterm infants disproportionately bear the morality burden, as they comprise 11.4% of livebirths, but 66.4% of deaths.  
▫ Infant mortality per 1,000 livebirths was 11.11 for non-Hispanic blacks vs. 5.06 for non-Hispanic whites, largely 
attributed to disparities in death from prematurity and SIDS (3 and 2 times higher mortality, respectively).  
13 
United 
States 
Prospective 
cohort and 
retrospective 
review 
  
2007-2010 
▫ 18.6% of HIV-exposed infants are preterm (n=1869), with highest rates of spontaneous preterm delivery among those 
with preconception cART (OR 1.59, 95% CI 1.10-2.30). 
▫ Preterm birth occurred among 155 of 748 women (21%) with first-trimester exposure to cART and among 155 of 924 
women (17%) with initial exposure to cART during the second or third trimester (P = .043, by the Fisher exact test).  
▫ Very preterm birth occurred among 3% of those with first-trimester exposure and among 1% of those with later exposure 
to combination regimens (P = .005, by the Fisher exact test), with risk up to 4 times greater with PI containing ART 
regimens, adjusted analysis (adjusted OR, 4.17; 95% CI, 1.70–10.26; P = .003), compared with no combination regimen in 
the first trimester.  
14 
United 
States 
Prospective 
cohort 
2001-2011 
▫ Of 183 HIV-exposed infants, 31.2% were small for gestational age ≤10th percentile, with 12.6% weighing ≤3rd 
percentile. 
15 France 
Prospective 
cohort 
2005-2009 
▫ HIV-exposed infants (n=11,377) were twice as likely as the general population to be premature, with rates highest among 
those with preconception treatment. 
16 
High 
Income 
Countries 
Confounder-
adjusted 
meta-analyses 
2016 
▫ 11 studies showed 35% reduction (95% CI 14–51) in type 2 diabetes; 
▫ 23 high-quality studies with ≥1500 participants showed 13% lower overweight/obesity (95% CI 6–19);  
▫ 29 studies on asthma showed 9% (95% CI 2–15) reduction;  
▫ 18 studies on childhood leukemia showed 19% (95% CI 11–27) reduction; and, 
▫ 16 studies showed child intelligence quotient (IQ) increased by 3.4 points (95% CI 2.3–4.6). 
17 Israel  Case-control 1995-2003 
▫ Among 6198 preterm infants (<37 weeks), BF significantly decreased urosepsis (OR 0.314, 95% CI 0.140–0.707, 
P < 0.009). 
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18 
High 
Income 
Countries 
Systematic 
review and 
meta-analysis  
2007 
▫ 4 randomized-controlled trials demonstrate BF decreases NEC 58% (95% CI 4-82). 
▫ In 23 studies, comprising 4,251 cases and 58,055 controls, “the overall risk of SIDS was twice as great for bottle-fed 
infants compared to [BF] infants,” (OR 2.11; 95% CI 1.66–2.68). 
▫ BF prevents gastroenteritis (OR 0.36, 95% CI 0.18–0.74, P=0.005) and hospitalization for respiratory infections (RR 
0.28, 95% CI 0.14–0.54). 
▫ Sub-analysis of 6 high-quality studies showed BF decreased SIDS by 36% (95% CI 19–49), adjusted summary odds ratio 
[SOR]: 0.64 [95% confidence interval (CI): 0.51–0.81]).  
19 
United 
Kingdom 
Systematic 
review and 
economic 
model 
2013 
▫ A model of the impact of BF on preterm infants (n=51,703, the number born in the index year) demonstrated 190 fewer 
deaths from sepsis and NEC if the infants were BF vs. formula-fed while in the NICU.  
20 
High 
Income 
Countries 
Meta-analysis 1995-2009 
▫ The multivariable pooled estimate revealed decreased SIDS with any BF (OR 0.55, 95% CI: 0.44–0.69). 
▫ SIDS risk is lowest with exclusive BF (OR 0.27; 95% CI, 0.27–0.31).  
21 
United 
States 
Monte Carlo 
simulation 
and cost-
analysis 
2016 
▫ An estimated 721 excess pediatric deaths/year were attributed to suboptimal BF in the US, mostly from SIDS (n = 492) 
and NEC (n = 190). 
▫ Increased uptake of BF decreased this estimate from 911 excess deaths in 2010. 
22 
United 
States 
National 
surveillance 
data 
2014 
▫ Acute lower respiratory and gastrointestinal infections caused 476 US infant deaths (12/100,000 livebirths). 
▫ 275 deaths of children <15 years old from sepsis. 
23 
United 
States 
Umbrella 
review 
2016 ▫ Acute otitis media, which affects ˃80% under 3 years, is decreased by 40-50% with BF (OR 0.50, 95% CI 0.36–0.70). 
24 
United 
States 
National 
surveillance 
data 
2014 
▫ Mortality from perinatal HIV is extremely low: there was 1 death among 1,995 children <13 with perinatal HIV, 
0.05/100 child-years. 
25 
United 
States 
National 
surveillance 
data and 
population-
based surveys 
 
2014-2015 
Healthy People 2020 Objectives: 
▫ 81.1% of US women initiate BF; target 81.9% 
▫ 51.8% are BF at 6 months; target 60.6% 
▫ 30.7% are BF at 1 year; target 34.1% 
▫ Exclusively BF at 3 months: 44.4%; target 46.2% 
▫ Exclusively BF at 6 months:22.3%; target 25.5% 
▫ Reduce proportion of BF newborns who receive formula supplementation in first two days of life: 17.1%; target 14.2% 
▫ Increase proportion of livebirths occurring in facilities providing recommended lactation care: 18.3%; target 8.1% 
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Table 3: Impact of Breastfeeding on Maternal Health in High Income Countries 
Ref Location 
 Study 
design 
Years 
(data 
collection, if 
available, 
or  
publication) 
Data 
 
BF= breastfeeding 
26 United States 
Secondary 
analysis of 
prospective 
cohorts  
1994-2005 
▫ Among 139,681 parous participants in the Women’s Health Initiative, women who had lactated were less likely to be 
obese, hypertensive, diabetic or hyperlipidemic than those who had not, with direct dose-response observed. 
27 United States 
Secondary 
analysis of 
prospective 
cohort 
1986-2002 
▫ In the Nurses’ Health Study of 89,326 parous women over 1,350,965 years of follow-up demonstrated that 2 years of 
cumulative lifetime BF reduced myocardial infarction by 23% (95% CI 6–38%, p-value=0.02), with 34% reduction (HR 
0.66, 95% CI, 0.49-0.89) in first 30 years after last delivery. 
28 United States 
Secondary 
analysis of 
prospective 
cohort 
1991-2005 
▫ Women who never BF are more likely to develop hypertension than those who BF ≥6 months (HR 1.29, 95% CI: 1.20-
1.40). 
29 
United States, 
Italy, Canada, 
Australia, 
Poland, 
China, and 
Sweden 
Meta-analysis 1992-2013 
▫ Analysis of 8,981 women with endometrial cancer and 17,241 control women demonstrated that ever having BF was 
associated with an 11% reduction in risk of endometrial cancer (pooled OR 0.89, 95% CI 0.81-0.98). 
30 
United 
Kingdom 
Cross-
sectional 
analysis of 
population-
based survey 
1996-2001 ▫ BMI decreased 1% per 6 months of BF among 740,628 British women. 
31 
United States, 
Germany, 
Australia, and 
China 
Systematic 
review and 
meta-analysis 
1989-2008 
▫ Meta-analysis demonstrates 32% lower risk of type 2 diabetes (OR 0.68, 95% CI 0·57–0·82), with risk decreasing 
~11% per 3 months of BF. 
32 
High Income 
Countries 
Systematic 
review and 
meta-analysis 
2015 
▫ Meta-analysis of 72 studies showed 19% decrease in breast carcinoma (pooled OR 0.81, 95% CI 0.77-0.85, p<.001) 
with any BF compared to never BF, and after fine adjustment of international data for parity and other confounders risk 
was reduced 7% (OR 0.93, 95% CI 0.89–0.97). 
▫ 35 studies on ovarian cancer demonstrated 26% reduction with any BF (OR 0.74, 95% CI 0.68–0.80, p<.001), and 18% 
reduction in finely adjusted sub-analysis of international data (OR 0.82, 95% CI 0.75–0.89). 
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33 International 
Systematic 
review and 
meta-analysis 
1960-2010 
▫ Among parous women, BF has a stronger inverse association with hormone/triple-negative breast cancer (OR 0.78; 95% 
CI 0.66–0.91) than BF alone. 
▫ Meta-analysis shows a protective effect of ever BF against hormone receptor-negative breast cancers, which are more 
common in younger women and generally have a poorer prognosis than other subtypes of breast cancer. 
▫Because black women have elevated baseline risk of hormone-and-triple-negative breast cancers, BF decreases their risk 
by 19%. 
34 United States 
Retrospective 
case-control 
with Arizona 
state 
surveillance 
data 
2003-2007 
▫ Among 1466 singleton infant deaths, short interpregnancy intervals significantly increased mortality and preterm birth, 
even after adjusting for confounders. 
▫ Mortality risk was increased with short birth intervals (aOR 1.68, 95% CI 1.09–2.59, p <.05) vs. the optimal interval 
(18–23 months); infant mortality is 76 % higher for interpregnancy interval <6 months and 38 % higher for 12–17 
months. 
▫ After adjusting for confounders, short intervals increased risk for subsequent preterm birth: aOR 4.44 (95% CI, 3.35–
5.89, p<.01), and small for gestational age: aOR 1.96 (95% CI 1.45–2.66, p<.01). 
35 
Latin 
America; 
United States 
Retrospective 
cohort study 
1985-1997; 
1989-1997 
▫ Among 456,889 Latin American women, maternal death was more likely with interpregnancy interval <6 months (aOR 
2.5; 95% CI 1.2-5.4) 
▫ A second pregnancy within 12 months postpartum significantly increased the risk of placental abruption by 52% and 
111% among women whose first births were vaginal and cesarean, respectively. Interpregnancy intervals <12 months 
were associated with 70% increased risk of placenta previa for women with a prior cesarean first birth (n= 156,475; RR 
1.7, 95% ci 0.9-3.1). 
36 
Brazil, 
Philippines, 
and 
Zimbabwe 
Meta-analysis 1982-2004 
▫ Subsequent pregnancies are also affected, as birth intervals <18 months are independently associated with SGA (aOR 
1.51), prematurity (aOR 1.58), and infant mortality (aOR 1.83). 
37 United States 
Monte Carlo 
simulation 
and cost-
analysis 
2016 ▫ Approximately 2,605 maternal deaths per year are attributed to suboptimal initiation and duration of BF. 
38 United States 
National 
surveillance 
data 
2015 
Examples of Racial and Ethnic Health Disparities: 
▫ % of pregnancies that are unintended: Black (69%), Hispanic (56%), White (42%) 
▫ % of livebirths that are premature: Black (17%), Hispanic (12%), White (10%) 
▫ Maternal deaths per 100,000 livebirths: Black (26), Hispanic (5), White (7) 
▫ Breast cancer deaths per 100,000 population: Black (31), Hispanic (15), White (22) 
▫ Diabetes-related deaths per 100,000 population: Black (33), Hispanic (13), White (24) 
39 United States 
Secondary 
analysis of 
observational 
study data 
1993-2010 
In confounder-adjusted analysis of the Women's Health Initiative Observational Study data: 
▫ Ever BF had a 23% lower risk of stroke than never BF (adjusted hazard ratio=0.77; 95% confidence interval 0.70‐0.83).  
▫ Stroke risk was most decreased with BF among non‐Hispanic black women (adjusted hazard ratio=0.52; 95% 
confidence interval 0.37‐0.71).   
▫ Breastfeeding for a relatively short duration (1‐6 months) was associated with a 19% lower risk of stroke (adjusted 
hazard ratios=0.81; 95% confidence interval 0.74‐0.89). 
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